StarZero All shows Try the podcast clipper →

checkpoint inhibitors

3 statements across 2 episodes · 2 bullish · 1 bearish · 1 people on the record · first statement Mar 2, 2020 by Jonathan Lim · across every show →

Everything said about checkpoint inhibitors, oldest first

Mar 2, 2020 positive
Assertion Supported
Lim: Checkpoint inhibitors yield five-year survival for one-third of metastatic melanoma patients
“The data here show you that with checkpoint inhibitors, as many as a third of patients reached that important five-year mark.”
Jonathan Lim Mar 2, 2020 ▶ 10:25 The 5 Revolutions in Cancer Treatment
Mar 2, 2020 negative
Assertion Supported
Lim: Majority of solid tumor patients do not respond to immunotherapy
“Checkpoint inhibitors have since been approved in multiple solid tumor types outside of metastatic melanoma, and the story holds true where you have a minority of patients that reach that five-year mark, what we call the long tail of survival, but still the ma…”
Jonathan Lim Mar 2, 2020 ▶ 10:49 The 5 Revolutions in Cancer Treatment
Apr 30, 2025 positive
Assertion Supported
Checkpoint inhibitors achieve long-term cures in roughly 20% of patients
“Especially with the checkpoint inhibitors where you see the long tail. So you see about 20% of patients that have long term remission that, that actually turns into cures.”
Jonathan Lim Apr 30, 2025 ▶ 6:50 Biotech CEO on where we are in the fight to cure cancer
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more